You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1335-ESGO The impact of combination of systemic inflammatory and molecular markers on survival of apparent early-stage endometrial cancer

Alerts

Article menu

Download PDFPDF

Endometrial cancer
2022-RA-1335-ESGO The impact of combination of systemic inflammatory and molecular markers on survival of apparent early-stage endometrial cancer
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address